These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29978156)

  • 61. Euglycemic clamp study in clozapine-induced diabetic ketoacidosis.
    Avram AM; Patel V; Taylor HC; Kirwan JP; Kalhan S
    Ann Pharmacother; 2001 Nov; 35(11):1381-7. PubMed ID: 11724088
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Management of decompensated diabetes. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome.
    Magee MF; Bhatt BA
    Crit Care Clin; 2001 Jan; 17(1):75-106. PubMed ID: 11219236
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis Presenting With Severe Abdominal Pain Mimicking Acute Peritonitis.
    Wang Q; Wu K; Luo X; Dong X; Liu W; Tang Z; Zhang B
    Cureus; 2022 Feb; 14(2):e22229. PubMed ID: 35340523
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use.
    Melnick S; Rajagopalan P; Lynn T; Donato A
    J Community Hosp Intern Med Perspect; 2018; 8(5):315-316. PubMed ID: 30357044
    [No Abstract]   [Full Text] [Related]  

  • 65. Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes.
    Henry RR; Thakkar P; Tong C; Polidori D; Alba M
    Diabetes Care; 2015 Dec; 38(12):2258-65. PubMed ID: 26486192
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Steroid-Induced Diabetic Ketoacidosis: A Case Report and Review of the Literature.
    Cavataio MM; Packer CD
    Cureus; 2022 Apr; 14(4):e24372. PubMed ID: 35611043
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strawberry pink blood: hypertriglyceridaemia and diabetic ketoacidosis secondary to poorly controlled type 2 diabetes mellitus.
    Tan TXZ; Lim SHC; Khoo J
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34417241
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Spotlight on Canagliflozin 300: review of its efficacy and an indirect comparison to other SGLT-2 inhibitors and long-acting GLP-1 receptor agonists.
    Singh AK; Singh R
    Expert Rev Clin Pharmacol; 2017 Jun; 10(6):633-647. PubMed ID: 28393583
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report.
    Mendelsohn RA; Taveras AN; Mazer BA; Clayton LM
    Clin Pract Cases Emerg Med; 2020 Aug; 4(3):389-392. PubMed ID: 32926693
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SGLT-2 Inhibitors-a Culprit of Diabetic Ketoacidosis Postbariatric Surgery.
    Iqbal QZ; Mishiyev D; Niazi MR; Zia Z; Sattar SBA; Jahanghir A; Quyyumi S
    Case Rep Crit Care; 2020; 2020():8817829. PubMed ID: 33204542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute Pancreatitis-Induced Euglycemic Diabetic Ketoacidosis.
    Chaudhry A; Biggiani C; Afzal M; Chaudhry S; Vwich Y
    Cureus; 2021 Jun; 13(6):e15949. PubMed ID: 34336446
    [TBL] [Abstract][Full Text] [Related]  

  • 72. People with type 1 diabetes using short acting analogue insulins are less dehydrated than those with using human soluble insulin prior to onset of diabetic ketoacidosis.
    Dhatariya K
    Med Hypotheses; 2008 Nov; 71(5):706-8. PubMed ID: 18694627
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
    Goldenberg RM; Berard LD; Cheng AYY; Gilbert JD; Verma S; Woo VC; Yale JF
    Clin Ther; 2016 Dec; 38(12):2654-2664.e1. PubMed ID: 28003053
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Who Underwent Surgery for Pancreatic Carcinoma: A Case Report.
    Luo X; Ji R; Lu W; Zhu H; Li L; Hu J
    Front Surg; 2022; 9():769041. PubMed ID: 35284482
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study.
    Patel NS; Van Name MA; Cengiz E; Carria LR; Weinzimer SA; Tamborlane WV; Sherr JL
    Diabetes Technol Ther; 2017 Nov; 19(11):618-622. PubMed ID: 29068709
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.
    Thiruvenkatarajan V; Meyer EJ; Nanjappa N; Van Wijk RM; Jesudason D
    Br J Anaesth; 2019 Jul; 123(1):27-36. PubMed ID: 31060732
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolic encephalopathy secondary to diabetic ketoacidosis: a case report.
    Tomkins M; McCormack R; O'Connell K; Agha A; Merwick Á
    BMC Endocr Disord; 2019 Jul; 19(1):71. PubMed ID: 31266485
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
    Fukuyama Y; Numata K; Yoshino K; Santanda T; Funakoshi H
    Acute Med Surg; 2020; 7(1):e480. PubMed ID: 31988792
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute mountain sickness induced diabetic ketoacidosis managed with hemodialysis: A case report.
    Pandit K; Khanal S; Adhikari S; Acharya SP
    Ann Med Surg (Lond); 2020 Aug; 56():165-168. PubMed ID: 32637094
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Journey of Diagnosing a Case of Immune Checkpoint Inhibitor Pembrolizumab-Induced Diabetes Mellitus.
    Tang M; Nakapakorn C; Meng S
    JCEM Case Rep; 2024 Jan; 2(1):luad126. PubMed ID: 38116162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.